These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10996949)

  • 1. [Generic drugs in Spain: first stage].
    Siles Gutiérrez M; Goldaracena Tanco M
    Aten Primaria; 2000; 26(3):162-8. PubMed ID: 10996949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evolution of pharmaceutical provision in the National Health System (1984-1994)].
    Crespo Sánchez-Eznarriaga B; Guerra Aguirre FJ
    Aten Primaria; 1995 Nov; 16(9):546-50. PubMed ID: 8562821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Utilization of generic drugs in Spain and Catalonia: possibilities of savings].
    Torralba Guirao M; Gilabert Perramon A; Peláez de Loño J; Faixedas Brunsoms MT
    Aten Primaria; 2000 Sep; 26(4):210-5. PubMed ID: 11100580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differences between prescription and dispensing of generic medicines in primary care. When the exception is the rule].
    Díez JI; Benounna H; Mayol CV; García RM
    Gac Sanit; 2007; 21(5):404-6. PubMed ID: 17916305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The introduction of generic pharmaceutical products into Galicia].
    Verdejo González A; López-Lázaro L; Rodríguez Moreno C; Piñeiro Lago B; Pereira Martínez ML
    Aten Primaria; 1999 Nov; 24(9):528-32. PubMed ID: 10687221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Generic drug prescription at discharge from a hospital emergency service].
    Vallano A; Fortuny J; Arnau JM; Laporte JR
    Med Clin (Barc); 2003 Nov; 121(17):645-9. PubMed ID: 14642224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of prescription of generic drugs for cost containment in pharmaceutics. Analysis in the Community of Navarra].
    Ansa Erice I; Agudo Pascual C; Artazcoz Sanz M; Carnicero Giménez de Azcárate J
    Aten Primaria; 1996 Apr; 17(6):411-4. PubMed ID: 8672647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prescription of generic drugs in the health area of Zamora. Benefits for the users and the National Health Service].
    Díaz Madero A; López Ferreras A
    Aten Primaria; 1997 Nov; 20(9):499-504. PubMed ID: 9477634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden.
    Andersson K; Sonesson C; Petzold M; Carlsten A; Lönnroth K
    Pharmacoepidemiol Drug Saf; 2005 May; 14(5):341-8. PubMed ID: 15624198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consumption of prescribed and over-the-counter medicines with prolonged oral clearance used by the elderly in the Northern Region of England, with special regard to generic prescribing, dose form and sugars content.
    Baqir W; Maguire A
    Public Health; 2000 Sep; 114(5):367-73. PubMed ID: 11035458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generic drug utilisation on the General Medical Services (GMS) scheme in 2001.
    Tilson L; McGowan B; Ryan M; Barry M
    Ir Med J; 2003 Jun; 96(6):176-9. PubMed ID: 12926759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Potential impact of measures to minimize drug costs in Aragon's primary care system].
    Siles Gutiérrez M; García Latorre FJ; Abad Díez JM; Bazo Fernández E; Camarena Fuertes Y; Muñoz Espílez F
    Aten Primaria; 1999 Apr; 23(6):352-8. PubMed ID: 10372458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of brands in the prescription of generic drugs at 6 health centers in 2001].
    Carmona Ibáñez G; Guevara Serrano J
    Aten Primaria; 2003 Oct; 32(7):415-9. PubMed ID: 14622554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Consumption of generic drugs in Area 1 of the Autonomous Community of Aragón].
    Camarena Fuertes Y; Sicilia Ruiz A
    Aten Primaria; 1999 Mar; 23(5):301-5. PubMed ID: 10341463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Do we primary care doctors improve our prescription of generic medicines after the intervention of the area pharmacist?].
    Gandía-Moya MC
    Aten Primaria; 2006 Apr; 37(7):386-91. PubMed ID: 16733020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia.
    Chua GN; Hassali MA; Shafie AA; Awaisu A
    Health Policy; 2010 May; 95(2-3):229-35. PubMed ID: 20044165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potential impact of measures to minimise costs of pharmaceutical provision in the province of Toledo].
    Criado-Alvarez JJ; Rodríguez Caravaca G; Gonseth J; Romo Barrientos C
    Aten Primaria; 2004 Feb; 33(3):126-30. PubMed ID: 14987495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of generic and essential medicines for prevention and treatment of cardiovascular diseases in Portugal.
    Gama H; Torre C; Guerreiro JP; Azevedo A; Costa S; Lunet N
    BMC Health Serv Res; 2017 Jun; 17(1):449. PubMed ID: 28662649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of rational prescribing and dispensing of medicines in Mali].
    Maiga D; Diawara A; Maiga MD
    Rev Epidemiol Sante Publique; 2006 Dec; 54(6):497-505. PubMed ID: 17194981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of prescription in discharge reports at a university hospital].
    Matoses Chirivella MC; Nájera Pérez MD; León Villar J; Iranzo Fernández MD; Plaza Aniorte J; Munilla Das A; Romero Crespo I; Ventura López M
    Farm Hosp; 2004; 28(3):180-7. PubMed ID: 15222871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.